ClinicalTrials.Veeva

Menu

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Myeloproliferative Neoplasm

Study type

Observational

Funder types

Other

Identifiers

NCT06462664
29BRC24.0134 - EMYNEM

Details and patient eligibility

About

Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of MPN in the participating center
  • Over 18 yo

Exclusion criteria

  • Not able to consent

Trial contacts and locations

1

Loading...

Central trial contact

Wayne Corentin LAMBERT; Eric LIPPERT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems